Literature DB >> 7625785

Combination effect of fosfomycin and ofloxacin against Pseudomonas aeruginosa growing in a biofilm.

H Kumon1, N Ono, M Iida, J C Nickel.   

Abstract

We examined the combined effect of fosfomycin and ofloxacin against Pseudomonas aeruginosa in biofilms by using an in vitro experimental system with a modified Robbins device. Sessile cells in a mature or immature biofilm, developed on a silicon disk, were used, and an ATP bioluminescence assay was employed to assess antibacterial effects. A synergistic effect of fosfomycin and ofloxacin was clearly detected when concentrations at which each drug independently produced no detectable decrease in the bioactivity of sessile cells were used. Exposure of the cells in a mature biofilm to fosfomycin at concentrations of one-eighth of the MIC to 10 times the MIC (6.25 to 500 micrograms/ml) and ofloxacin at three or 10 times the MIC (18.75 or 62.5 micrograms/ml) resulted in reduction of the bioactivity to 1.5 to 4.5% after 72 h. Young sessile cells in an immature biofilm were more susceptible to this combination therapy. With a combination of fosfomycin at three times the MIC and ofloxacin at three times the MIC, complete eradication was confirmed by both ATP assay and scanning electron microscopy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7625785      PMCID: PMC162679          DOI: 10.1128/AAC.39.5.1038

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  Interaction of biofilm bacteria with antibiotics in a novel in vitro chemostat system.

Authors:  H Anwar; T van Biesen; M Dasgupta; K Lam; J W Costerton
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

2.  Inhibition of the antibacterial activity of gentamicin by urine.

Authors:  J N Minuth; D M Musher; S B Thorsteinsson
Journal:  J Infect Dis       Date:  1976-01       Impact factor: 5.226

3.  Pharmacokinetics of ofloxacin after parenteral and oral administration.

Authors:  H Lode; G Höffken; P Olschewski; B Sievers; A Kirch; K Borner; P Koeppe
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

4.  Phosphonomycin, a new antibiotic produced by strains of streptomyces.

Authors:  D Hendlin; E O Stapley; M Jackson; H Wallick; A K Miller; F J Wolf; T W Miller; L Chaiet; F M Kahan; E L Foltz; H B Woodruff; J M Mata; S Hernandez; S Mochales
Journal:  Science       Date:  1969-10-03       Impact factor: 47.728

5.  Inhibition of tobramycin diffusion by binding to alginate.

Authors:  W W Nichols; S M Dorrington; M P Slack; H L Walmsley
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

6.  Synergy of ciprofloxacin with fosfomycin in vitro against Pseudomonas isolates from patients with cystic fibrosis.

Authors:  V M Figueredo; H C Neu
Journal:  J Antimicrob Chemother       Date:  1988-07       Impact factor: 5.790

7.  Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material.

Authors:  J C Nickel; I Ruseska; J B Wright; J W Costerton
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

8.  Antibiotic interaction and diffusion through alginate and exopolysaccharide of cystic fibrosis-derived Pseudomonas aeruginosa.

Authors:  C A Gordon; N A Hodges; C Marriott
Journal:  J Antimicrob Chemother       Date:  1988-11       Impact factor: 5.790

9.  A sandwich cup method for the penetration assay of antimicrobial agents through Pseudomonas exopolysaccharides.

Authors:  H Kumon; K Tomochika; T Matunaga; M Ogawa; H Ohmori
Journal:  Microbiol Immunol       Date:  1994       Impact factor: 1.955

10.  The mechanism of action of fosfomycin (phosphonomycin).

Authors:  F M Kahan; J S Kahan; P J Cassidy; H Kropp
Journal:  Ann N Y Acad Sci       Date:  1974-05-10       Impact factor: 5.691

View more
  15 in total

1.  The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms.

Authors:  H Ceri; M E Olson; C Stremick; R R Read; D Morck; A Buret
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

Review 2.  Fluoroquinolones in urinary tract infections. Proper and improper use.

Authors:  K G Naber
Journal:  Drugs       Date:  1996       Impact factor: 9.546

3.  In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin against Pseudomonas aeruginosa.

Authors:  F Tessier; C Quentin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-02       Impact factor: 3.267

Review 4.  Collective antibiotic tolerance: mechanisms, dynamics and intervention.

Authors:  Hannah R Meredith; Jaydeep K Srimani; Anna J Lee; Allison J Lopatkin; Lingchong You
Journal:  Nat Chem Biol       Date:  2015-02-17       Impact factor: 15.040

Review 5.  A reappraisal of current dosing strategies for intravenous fosfomycin in children and neonates.

Authors:  Friederike Traunmüller; Martin Popovic; Karl-Heinz Konz; Patrick Vavken; Andreas Leithner; Christian Joukhadar
Journal:  Clin Pharmacokinet       Date:  2011-08       Impact factor: 6.447

6.  Eradication of Pseudomonas aeruginosa biofilms on cultured airway cells by a fosfomycin/tobramycin antibiotic combination.

Authors:  Gregory G Anderson; Thomas F Kenney; David L Macleod; Noreen R Henig; George A O'Toole
Journal:  Pathog Dis       Date:  2013-01-10       Impact factor: 3.166

7.  Intraluminal diamond-like carbon coating with anti-adhesion and anti-biofilm effects for uropathogens: A novel technology applicable to urinary catheters.

Authors:  Shogo Watari; Koichiro Wada; Motoo Araki; Takuya Sadahira; Daiki Ousaka; Susumu Oozawa; Tatsuyuki Nakatani; Yuichi Imai; Junichi Kato; Reiko Kariyama; Toyohiko Watanabe; Yasutomo Nasu
Journal:  Int J Urol       Date:  2021-09-04       Impact factor: 2.896

8.  Novel antibiotic susceptibility tests by the ATP-bioluminescence method using filamentous cell treatment.

Authors:  N Hattori; M O Nakajima; K O'Hara; T Sawai
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

9.  The influence of bacterial biofilm on the clinical outcome of chronic rhinosinusitis: a prospective, double-blind, scanning electron microscopy study.

Authors:  Roman Głowacki; Krzysztof A Tomaszewski; Paweł Stręk; Iwona M Tomaszewska; Katarzyna Zgórska-Świerzy; Beata Markiewicz; Jacek Składzień
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-07-18       Impact factor: 2.503

10.  Bactericidal effect of pefloxacin and fosfomycin against Pseudomonas aeruginosa in a rabbit endocarditis model with pharmacokinetics of pefloxacin in humans simulated in vivo.

Authors:  D Bugnon; G Potel; Y Q Xiong; J Caillon; D Navas; C Gras; M F Kergueris; P Le Conte; F Jehl; D Baron; H Drugeon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.